Abstract
Mammalian tissues contain two types of cannabinoid receptors CB1 and CB2. The aim of our study was an evaluation of the influence of a single i.p. injection of a stable analogue of an endogenous cannabinoid anandamide--R-(+)-methanandamide (2.5 mg/kg) and CP 55,940 (0.25 mg/kg), which is an exogenous agonist of CB1 receptors, on the immunoreactivity of regulatory peptides, produced in rat thyroid C cells: calcitonin, CGRP, somatostatin and synaptophysin. This study indicates that a single injection of cannabinoids: R-(+)-methanandamide and CP 55,940 alters the immunoreactivity of regulatory peptides in thyroid parafollicular cells.
MeSH terms
-
Animals
-
Arachidonic Acids / pharmacology*
-
Calcitonin Gene-Related Peptide / metabolism
-
Cannabinoids / pharmacology*
-
Cyclohexanols / pharmacology
-
Endocannabinoids
-
Male
-
Polyunsaturated Alkamides
-
Rats
-
Rats, Wistar
-
Receptor, Cannabinoid, CB1 / drug effects
-
Receptor, Cannabinoid, CB1 / physiology
-
Receptor, Cannabinoid, CB2 / drug effects
-
Receptor, Cannabinoid, CB2 / physiology
-
Somatostatin / metabolism
-
Synaptophysin / metabolism
-
Thyroid Gland / drug effects
-
Thyroid Gland / physiology*
Substances
-
Arachidonic Acids
-
Cannabinoids
-
Cnr2 protein, rat
-
Cyclohexanols
-
Endocannabinoids
-
Polyunsaturated Alkamides
-
Receptor, Cannabinoid, CB1
-
Receptor, Cannabinoid, CB2
-
Synaptophysin
-
methanandamide
-
Somatostatin
-
3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol
-
Calcitonin Gene-Related Peptide
-
anandamide